Late poor outcomes of Clostridioides difficile infections in oncological patients: A multicentre cohort study.

Oncological patients presented a higher risk of poor outcomes after CDI. Their early and late mortality rates were higher than in the general population, and in parallel, those undergoing chemotherapy (especially those receiving metronidazole) had higher rates of recurrence.